- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03742817
Effects of e-Cigarettes on Perceptions and Behavior
July 7, 2023 updated by: Adam Leventhal, University of Southern California
This project will assess the ways in which e-cigarette product diversity impacts the user experience to inform potential regulations by identifying product characteristics that may: (1) put young adults at risk for tobacco product use; and (2) facilitate adult smokers switching to e-cigarettes.
There are three primary objectives to the study: (1) Determine which dimensions of e-cigarette product diversity differentially affect product appeal across young adult e-cigarette users and middle-age/older adult smokers with an interest in, but no significant experience with, e-cigarettes; (2) Determine which dimensions of e-cigarette product diversity differentially affect abuse liability in young adult e-cigarette users and the ability to resist smoking in adult smokers with an interest in, but no significant experience with, e-cigarettes; (3) Determine the affect of product characteristics on e-cigarette nicotine delivery profile.
For Aim 1, young adult vapers (N=200) and adult smokers (N=200) will attend one laboratory session in which they will self-administer e-cigarette products varied according to within-subject e-cigarette factors (e.g., flavor, pg/vg ratio).
For Aim 2, young adults vapers (N=360) and adult smokers (N=360) will administer an e-cigarette product and complete behavioral economic tasks that test the participant's choice of earning money to delay initiation and continued use of: (1) The sampled e-cigarette product (abuse liability; young adult vapers); or (2) Their own brand cigarettes (ability to resist smoking; adult current smokers).
A pilot study will establish device and e-liquid parameters (e.g., nicotine concentration) to be used for all aims.
Study Overview
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90033
- University of Southern California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
Vapers
- E-cigarette use >3 day/week for >2 months
- Report regularly using e-cigarette products with nicotine
- Positive cotinine test via NicAlert test strip
Smokers
- Daily cigarette smoking for ≥ 2 years
- Currently smoke > 4 cig/day
- Interest in trying an e-cigarette or current use of e-cigarettes
Exclusion Criteria:
Vapers
- Pregnancy/breastfeeding
- Desire to immediately reduce e-cigarette use
Smokers
- Breath CO < 9ppm at intake
- Pregnancy / breastfeeding
- Current daily use of other combustible tobacco products (e.g., cigars)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Sweet-Flavor 4.5% Nicotine (Salt)
Participants will self-administer a sweet-flavored e-cigarette containing 4.5% nicotine by volume.
|
Participants will self-administer an experimenter-provided e-cigarette.
|
Placebo Comparator: Sweet-Flavor 0 mg/mL Nicotine (Free-Base)
Participants will self-administer a sweet-flavored e-cigarette containing 0 mg/mL nicotine.
|
Participants will self-administer an experimenter-provided e-cigarette.
|
Experimental: Sweet-Flavor 6 mg/mL Nicotine (Free-Base)
Participants will self-administer a sweet-flavored e-cigarette containing 6 mg/mL nicotine.
|
Participants will self-administer an experimenter-provided e-cigarette.
|
Active Comparator: Usual e-Cigarette
Participants will self-administer either their preferred brand combustible cigarette or e-cigarette with usual nicotine nicotine concentration.
|
Participants will self-administer an experimenter-provided e-cigarette.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Positive Affect Negative Affect Schedule
Time Frame: 4 hours
|
The 10-item Positive Affect Negative Affect Schedule (PANAS-SF) will be used to measure positive and negative affect.
|
4 hours
|
Subjective Appeal
Time Frame: 1 hour
|
Self-report measures of product appeal will be completed following the e-cigarette administration.
|
1 hour
|
Questionnaire of Vaping Urges
Time Frame: 4 hours
|
10-item Brief Questionnaire of Vaping Urges will assess desire, intention, urge and need to vape e-cigarettes.
|
4 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Adam M Leventhal, PhD, University of Southern California
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2019
Primary Completion (Actual)
March 1, 2020
Study Completion (Actual)
March 1, 2020
Study Registration Dates
First Submitted
November 14, 2018
First Submitted That Met QC Criteria
November 14, 2018
First Posted (Actual)
November 15, 2018
Study Record Updates
Last Update Posted (Actual)
July 11, 2023
Last Update Submitted That Met QC Criteria
July 7, 2023
Last Verified
July 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- HS-18-00839 - Pilot Study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electronic Cigarettes
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedElectronic CigarettesUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)TerminatedElectronic CigarettesUnited States
-
University of Southern CaliforniaCompleted
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)CompletedElectronic CigarettesUnited States
-
Virginia Commonwealth UniversityCompletedElectronic CigarettesUnited States
-
Virginia Commonwealth UniversityNational Institute on Drug Abuse (NIDA)Recruiting
-
Brown UniversityNational Institute on Drug Abuse (NIDA); University of Minnesota; Food and Drug... and other collaboratorsCompletedSmoking, Cigarette | Electronic CigarettesUnited States
-
Ludwig-Maximilians - University of MunichCompletedExposure to Electronic CigarettesGermany
-
University of MinnesotaNational Institutes of Health (NIH)Completed
-
State University of New York at BuffaloNational Institute on Drug Abuse (NIDA); Roswell Park Cancer InstituteRecruitingAcute Abstinence From Cigarettes vs E-cigarettes (ENDS)United States
Clinical Trials on e-Cigarette
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaFondazione Salvatore MaugeriCompleted
-
University of OklahomaCompletedSmoking CessationUnited States
-
University of California, San FranciscoNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); Roswell Park Cancer InstituteCompleted
-
University of California, Los AngelesTobacco Related Disease Research ProgramCompleted
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); University...CompletedNicotine Dependence | Smoking, Tobacco | Smoking, Cigarette | Exposure to Toxic AgentUnited States
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); University of MinnesotaCompletedTobacco Use DisorderUnited States
-
University of Southern CaliforniaCompletedElectronic Cigarette Use | Cigarette Smoking | Cigarette Use, Electronic | VapingUnited States
-
GWT-TUD GmbHTerminated
-
Dartmouth-Hitchcock Medical CenterVinfen Corporation; Centerstone KentuckyCompletedSchizophrenia | Schizoaffective Disorder | Bipolar Disorder | Tobacco DependenceUnited States
-
Fordham UniversityMontefiore Medical Center; Dartmouth CollegeRecruitingTobacco Smoking | Psychiatric DisordersUnited States